Specific HIV-1 reverse transcriptase inhibitors.
Debyser
Z
Z
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
Pauwels
R
R
Andries
K
K
De Clercq
E
E
D000998:Antiviral Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology*; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000201:enzymology*; D007093:Imidazoles / Q000494:pharmacology*; D008957:Models, Genetic; D018894:Reverse Transcriptase Inhibitors; D013941:Thymine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D015215:Zidovudine / Q000494:pharmacology*
D000998:Antiviral Agents; D007093:Imidazoles; D018894:Reverse Transcriptase Inhibitors; C061818:1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine; C062687:R 82150; D001569:Benzodiazepines; D015215:Zidovudine; C067413:R-82913; D054303:HIV Reverse Transcriptase; D013941:Thymine